Pharma Tech Outlook Conferences

LIVX is a first-of-its-kind global platform uniting the full healthcare ecosystem from biotech and life sciences to longevity, AI and Age Tech. Designed to break silos, LIVX connects innovators with regulators, investors, healthcare systems, and global markets to accelerate validation, partnerships, and scale.

The Pharma Partnering Summit is an international event focused on Business Development & Licensing deals, R&D Collaborations, Investment & Fundraising, Alliances, M&A, as well as Deal-making Opportunities in the broader aspect within Pharma Biotech Ecosystem.

U.S Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the U.S’s vibrant biotech ecosystem, spanning world-class research, dynamic startups, big pharma, and visionary investors, to drive breakthrough partnerships. Join us to discover new opportunities, forge strategic alliances, and help shape the next era of biotech success in the U.S and the world.

Biomarker Operations & Biospecimen Management Summit provides a long-overdue home to share experiences and define the standards this field now demands. Following the complete sample lifecycle, from kit design and site collection, through to tracking, storage, biobanking, lab coordination and data harmonization, walk away with the real-time insights needed to implement robust, scalable biomarker and biospecimen operations.

The 28th BioPharma Clinical Trials Nexus is an invitation-only, executive-level event that brings together senior clinical trial leaders from pharmaceutical and biotechnology organizations alongside carefully selected solution providers shaping the future of clinical research. Designed to move beyond the traditional trade show model, the Nexus creates a purpose-driven environment focused on knowledge exchange, peer-to-peer dialogue, and meaningful collaboration. The agenda is thoughtfully curated to address the most pressing challenges facing clinical trials today, while highlighting emerging trends, and innovative approaches that are already delivering measurable impact.

11th BioPharma Supply Chain & Logistics Nexus Conference, happening Nov 11–12, 2026, in San Diego, USA. This invitation-only, executive-level gathering brings together senior leaders from pharmaceutical and life sciences organizations with hand-picked solution providers shaping the future of supply chain management. Designed to move beyond the traditional conference format, the Nexus delivers a multi-dimensional experience focused on knowledge exchange, strategic collaboration, and actionable insights. Explore emerging trends and innovative solutions across advanced cold chain logistics, temperature-controlled distribution, regulatory compliance, sustainability initiatives, warehousing optimization, and inventory management strategies.

Bringing together 190+ leaders from pharma and biotech, the 9th Lab Asset & Facility Management Summit is the only event dedicated to the operational infrastructure that enables science. Discover practical approaches to asset optimization, facility excellence, and smarter lab operations.

The 5th Process Monitoring in Pharma Manufacturing Summit (formerly the PAT & Real Time Quality Summit) is where industry leaders come to turn ambition into execution. Designed for pharma, biotech, and CDMO teams driving process performance, the meeting focuses on shifting from fragmented tools to integrated, end-to-end monitoring strategies that deliver real business impact. Discover how leading organizations are transforming real-time data into predictive insight, enabling faster decision-making, reducing batch risk, and unlocking higher yield and efficiency.

The 14th IMPACCT Real-World Evidence Summit is the only dedicated industry forum uniting leaders across RWE, real-world data, evidence generation, HEOR, and market access to tackle the most pressing challenges in the field. From selecting regulatory-ready datasets to embedding AI and advanced analytics into workflows, this summit focuses on how to consistently translate data into actionable decisions.     Join leading experts from AstraZeneca, Pfizer, Novartis, Boehringer Ingelheim and more to build integrated evidence strategies, accelerate timelines, and maximize the ROI of real-world evidence investment

Discovery & Development US 2026 brings together 600+ senior pharma,  biotech and academic leaders across three connected programmed in San Diego,  12–13 October. From AI-driven target identification and ADC development to  biologics formulation and neuroscience drug discovery, this is where the R&D  community meets to accelerate the path from bench to clinic.